Articles in section Licensing

<< Joint Venture

505 articles

Mergers & Acquisitions >>

<< Previous

Pages 1 2 3 4 5 .. 51

Next >>

Karuna Pays US$15 M Upfront for Goldfinch Bio’s TRPC4/5 Inhibitors Published: 24 Feb-2023
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 2
UniQure Pays US$10 M Upfront for Apic Bio’s ALS Gene Therapy Published: 15 Feb-2023
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 2
Amgen Signs US$2 B Licensing Agreement with Synaffix for Next-Generation ADCs Published: 3 Feb-2023
By: Lalit Mishra & Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 2
Takeda Signs US$1.13 B Deal with Hutchmed for Colorectal Cancer Drug Published: 1 Feb-2023
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2023 Issue: 2
AbbVie Forms Auto-Immunology Partnership with HotSpot Therapeutics for US$335M Published: 21 Dec-2022
By: Swati Sharan
Abstract Fulltext:
Volume: 2022 Issue: 12
Novartis Signs License Agreement with MorphoSys to Develop and Commercialise Preclinical Inhibitors for Cancer Published: 21 Dec-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 12
Kite Enters into License Agreement with Arcellx for CART-ddBCMA in Multiple Myeloma Published: 16 Dec-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 12
Astellas Turns to AAV-based Gene Therapy with Taysha Gene Therapies Collaboration Deal Published: 9 Nov-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 11
Hookipa Pharma signs US$958 M Deal with Roche to develop HB-700 for KRAS-mutated Cancers Published: 5 Nov-2022
By: Amit Kaushik
Abstract Fulltext:
Volume: 2022 Issue: 11
Jazz Pharmaceuticals Enters into License Agreement with Zymeworks for Zanidatamab Published: 26 Oct-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 10

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

IQVIA™ Pharma Deals: PharmaDeals Review: Browse by Section